Alarcón-Almanza JM, Fuentes-García V, García-Cruz AE

Language: Spanish
References: 20
Page: 167-175
PDF size: 231.98 Kb.

ABSTRACT

Latex allergy remains an important entity in medical practice around the world as anaphylaxis that can develop secondarily often increases morbidity and in severe cases leads to death. Material and methods: A cross-sectional, analytical study of 300 patients who were applied a measuring instrument (questionnaire) for detection of probable allergy to latex, which consisted of 10 questions related to risk factors was performed more frequently found in the literature to develop this condition. They were assigned a score to each question depending on the clinical weight reported in the bibliographic references to determine the score according to whether patients had alert, probability or potential allergy latex allergy probability. This measuring instrument to all patients 1 was applied to 17 years of age, of both sexes, to be submitted to anesthetic procedure either on a schedule or emergency, from any service, with ASA I to III, They did not have an established diagnosis of latex allergy, while inpatient or outpatient basis. Results: The results yielded clinically the possibility to detect patients with probable allergic to latex. With the presence of red flags to this pathology we are allowed to take appropriate measures to medical personnel in charge of the management of these patients. Conclusion: Latex allergy is an entity that intentionally must be sought prior to the surgical event. The application of directed questions to dismiss or affirm likely presentation is required and must implement a measuring instrument, as in this case was the questionnaire to capture these patients and give them a management peri-appropriate operative, with all clothing and equipment be suspected.

REFERENCES

1. Faust K, Shreawsbury C, Zaglaniczny K, Jarrett M. A comparative analysis of latex allergy in the healthy versus high-risk pediatric population. AANA J. 1999;67:461-466.

2. Poley GE, Slater JE. Latex allergy. J Allergy Clin Immunol. 2000;105:1054-1062.

3. Hamilton RG, Biagini RE, Krieg EF. Diagnostic performance of Food and Drug Administration-cleared serologic assays for natural rubber latex-especific IgE antibody. J Allergy Clin Immunol. 1999;103:925-930.

4. Taylor JS, Erkek E. Latex allergy: diagnosis and management. Dermatol Ther. 2014;17:289-301.

5. Meade BJ, Weissman DN, Beezhold DH. Latex allergy: past and present. Int Immunopharmacol. 2002;2:225-238.

6. Ownby D. A history of latex allergy. J Allergy Clin Immunol. 2002;110:S27-S32.

7. Nieto A, Pamies R, Mazón A. Peculiaridades de la alergia a látex y medidas preventivas de la edad pediátrica. Allergol Immunopathol. 2002;30:148-156.

8. Sanz ML, García-Aviles MC, Tabar AI, Anda M, García BE, Barber D, et al. Basophil Activation Test and specific IgE measurements using a panel of recombinant natural rubber latex allergens to determine the latex allergen sensitization profile in children. Pediatr Allergy Immunol. 2006;17:148-156.

9. Guillet G, Guillet MH, Dagregorio G. Allergic contact dermatitis from natural rubber latex in atopic dermatitis and the risk of later Type I allergy. Contact Dermatitis. 2005;53:46-51.

10. De Queiroz M, Combent S, Bérard J, Pouyau A, Genest H, Mouriquand P, et al. Latex allergy in children: modalities and prevention. Paediatr Anaesth. 2009;19:313-319.

11. Cabañes N, Igea JM, De la Hoz B, Agustín P, Blanco C, Dominguez J, et al. Latex allergy: position paper. J Investig Allergol Clin Inmunol. 2012;22:313-330.

12. Yeang HY. Natural rubber latex allergens: new developments. Curr Opin Allerg Clin Immunol, 2004;4:99-104.

13. El-Sayed ZA, El-Sayed SS, Zaki RM, Salama MA. Latex hypersensitivity among allergy Egyptian children: relation to parental/self reports. Pulm Med. 2014;2014:629187

14. Reunala T, Alenius H, Turjanmaa K, Palosuo T. Latex allergy and skin. Curr Opin Allerg Clin Immunol. 2004;(4):397-401.

15. Khan S, Holding S, Doré P, Sewell C. Pitfalls in the diagnosis of latex allergy. Allergology International. 2010;(59):305-308.

16. Turjanmaa K, Makinen-Kiljunen S. Latex allergy: prevalence, risk factors, and cross reactivity. Methods. 2002;27:10-14.

17. Slater JE, Paupore E, Zhang YT, Colberg-Poley MA. The latex allergen Hev b 5 transcript is widely distributed after subcutaneous injection in BALB/c mice of its DNA vaccine. J Allergy Immunol. 1998;102:469-475.

18. Arenas-Venegas A. Alergia a látex en el paciente pediátrico. Rev Mex Anest. 2014;37:S98-S101.

19. Prescott S, Tang M, Australasian Society of Clinical Immunology and Allergy. The Australasian Society of Clinical Immunology and Allergy position statement: summary of allergy prevention in children. Med J Aust. 2005;183:464-467.

20. Turjanmaa K, Alenius H, Reunala T, Palosuo T. Recent developments in latex allergy. Curr Opin Allerg Clin Immunol, 2002;2:407-412.